Cytrellis Biosystems seals $28.5 mln Series B

Woburn, Massachusetts-based Cytrellis Biosystems, a medical technology company that’s developing new aesthetic devices, has secured $28.5 million in Series B funding. The investors included ARCH Venture Partners, the Merz Venture Initiative, Partner Fund Management and BioMatics Capital.

Source: Press Release